Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Search Startups

    Tagged as ('immunology') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage 

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status 

    55 Startups 4 In the News 4 Recently Updated
    • Total Funding
      $1.29B
      Raised
      70
      Events
    • Private Funding
      $965M
      Raised
      51
      Rounds
    • Public Offerings
      $228.1M
      Raised
      14
      Offerings
    • M&A
      $95M
      Raised
      5
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    Chemomab Therapeutics logo

    Chemomab Therapeutics

    Public
    Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases
    2011 B2B 11-50 Public $80.5M
    pharmaceuticals
    autoimmune-diseases
    immunology
    drug-delivery
    drug-discovery
    healthcare-providers
    treatments
    antibodies
    biopharmaceutical
    Compugen logo

    Compugen

    Public
    Drug Discovery Using Computational Modeling
    1993 B2B 51-200 Public $141.92M
    immunology
    oncology
    biotechnology
    bioinformatics
    antibodies
    drug-discovery
    proteins
    pharmaceuticals
    immunotherapy
    cancer-therapy
    autoimmune-diseases
    patients
    pharma-companies
    cancer
    Nectin Therapeutics logo

    Nectin Therapeutics

    Next-generation Immunotherapy Agents
    2017 B2B 11-50 A $36M
    biotechnology
    pharmaceuticals
    oncology
    immunology
    cancer-therapy
    cancer
    antibodies
    patients
    drug-delivery
    treatments
    Enlivex Therapeutics R&D logo

    Enlivex Therapeutics R&D

    Public
    Macrophage Reprogramming Cell Therapies for Life-threatening Diseases
    2005 B2B 11-50 Public $65.2M
    cell-therapy
    inflammatory-diseases
    crohn's-disease
    pharmaceuticals
    cancer
    immunology
    immunotherapy
    pharma-companies
    chronic-patients
    patients
    autoimmune-diseases
    Nano24 logo

    Nano24

    Next-generation of Immunomodulators
    2020 B2C 1-10 Seed $9.5M
    drug-development
    antibodies
    pharma-companies
    immunotherapy
    targeting
    biopharmaceutical
    targeted-therapy
    genetics
    immunology
    prevention
    nanotechnology
    biotechnology
    drug-discovery
    Immunai logo

    Immunai

    Peripheral Tissue Analysis
    2019 B2B 51-200 B $295M
    immunotherapy
    unicorn-2021
    digital-healthcare
    hospitals
    immunology
    data-analytics
    actionable-insights
    pharma-companies
    cancer
    autoimmune-diseases
    artificial-intelligence
    machine-learning
    deep-learning
    cells
    Life Matters logo

    Life Matters

    Fighting Antibiotic-resistant Bacteria via Biofilm Prevention
    2016 B2B 1-10 Pre-Funding Undisclosed
    medical-devices
    biotechnology
    pharmaceuticals
    hospitals
    pharma-companies
    biopharmaceutical
    immunology
    therapeutics
    ventilation
    respiratory
    life-sciences
    pulmonary
    infectious-disease
    bacteria
    animal-health

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    55 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $1.29B
      Raised
      70
      Events
    • Private Funding
      $965M
      Raised
      51
      Rounds
    • Public Offerings
      $228.1M
      Raised
      14
      Offerings
    • M&A
      $95M
      Raised
      5
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    Chemomab Therapeutics logo
    Raised
    $80.5M
    Chemomab Therapeutics
    Public
    Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases
    Founded:2011
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    Compugen logo
    Raised
    $141.92M
    Compugen
    Public
    Drug Discovery Using Computational Modeling
    Founded:1993
    Business Model:B2B
    Employees:51-200
    Funding Stage:Public
    Nectin Therapeutics logo
    Raised
    $36M
    Nectin Therapeutics
    Next-generation Immunotherapy Agents
    Founded:2017
    Business Model:B2B
    Employees:11-50
    Funding Stage:A
    Enlivex Therapeutics R&D logo
    Raised
    $65.2M
    Enlivex Therapeutics R&D
    Public
    Macrophage Reprogramming Cell Therapies for Life-threatening Diseases
    Founded:2005
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    Nano24 logo
    Raised
    $9.5M
    Nano24
    Next-generation of Immunomodulators
    Founded:2020
    Business Model:B2C
    Employees:1-10
    Funding Stage:Seed
    Immunai logo
    Raised
    $295M
    Immunai
    Peripheral Tissue Analysis
    Founded:2019
    Business Model:B2B
    Employees:51-200
    Funding Stage:B
    Life Matters logo
    Raised
    Undisclosed
    Life Matters
    Fighting Antibiotic-resistant Bacteria via Biofilm Prevention
    Founded:2016
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,